Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hana Baakza"'
Autor:
Elizabeth J. Wiseman, Jennifer I. Moss, James Atkinson, Hana Baakza, Emily Hayes, Sophie E. Willis, Paul M. Waring, Jaime Rodriguez Canales, Gemma N. Jones
Publikováno v:
Journal of Histochemistry & Cytochemistry. 71:237-257
Phosphorylated biomarkers are crucial for our understanding of drug mechanism of action and dose selection during clinical trials, particularly for drugs that target protein kinases, such as DNA-damage-response (DDR) inhibitors. However, tissue fixat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb63fb6a5e9d79c2925f480d3ec99393
https://doi.org/10.1369/00221554231174069
https://doi.org/10.1369/00221554231174069
Autor:
Maria Rosa Bani, Raffaella Giavazzi, Elaine B. Cadogan, Carmen Ghilardi, Joanne Wilson, Hana Baakza, Massimo Russo, Giovanna Chiorino, Neil James, Antonio Ramos-Montoya, Giulia Dellavedova, Alessia Anastasia
Supplementary Data from The DNA-PK Inhibitor AZD7648 Sensitizes Patient-Derived Ovarian Cancer Xenografts to Pegylated Liposomal Doxorubicin and Olaparib Preventing Abdominal Metastases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ef963a27f8df98bd291fe201e5ba3aa
https://doi.org/10.1158/1535-7163.22522287.v1
https://doi.org/10.1158/1535-7163.22522287.v1
Autor:
Maria Rosa Bani, Raffaella Giavazzi, Elaine B. Cadogan, Carmen Ghilardi, Joanne Wilson, Hana Baakza, Massimo Russo, Giovanna Chiorino, Neil James, Antonio Ramos-Montoya, Giulia Dellavedova, Alessia Anastasia
Ovarian cancer is the deadliest gynecologic cancer, with a 5-year survival rate of 30%, when the disease has spread throughout the peritoneal cavity.We investigated the efficacy to delay disease progression by the DNA-dependent protein kinase (DNA-PK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2299d1dadaee013f58ae3ea9ccd603d8
https://doi.org/10.1158/1535-7163.c.6543324
https://doi.org/10.1158/1535-7163.c.6543324
Autor:
Alessia Anastasia, Giulia Dellavedova, Antonio Ramos-Montoya, Neil James, Giovanna Chiorino, Massimo Russo, Hana Baakza, Joanne Wilson, Carmen Ghilardi, Elaine B. Cadogan, Raffaella Giavazzi, Maria Rosa Bani
Publikováno v:
Molecular Cancer Therapeutics. 21:555-567
Ovarian cancer is the deadliest gynecologic cancer, with a 5-year survival rate of 30%, when the disease has spread throughout the peritoneal cavity. We investigated the efficacy to delay disease progression by the DNA-dependent protein kinase (DNA-P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::307608bb1d7c89d9a0f28d83a41817e3
https://doi.org/10.1158/1535-7163.mct-21-0420
https://doi.org/10.1158/1535-7163.mct-21-0420